"Entwicklung von Wachstumsstrategien liegt in unserer DNA"
Female Sexual Dysfunction Treatment Market Size, Share & Industry Analysis, By Drug (Flibanserin, Bremelanotide, Ospemifene, Estrogen Therapy, and Others), By Disease (Hypoactive Sexual Desire Disorder (HSDD), Dyspareunia, and Others), By Route of Administration (Oral, Parenteral, and Topical), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), und regionale Prognose, 2025-2032
Letzte Aktualisierung: November 17, 2025
| Format: PDF
| Bericht-ID: FBI100850